Stability of vitamin K antagonist anticoagulation after COVID‐19 diagnosis

BACKGROUND: Coagulopathy has been reported in severely ill patients with coronavirus disease 2019 (COVID‐19). It is unclear whether outpatients with COVID‐19 who are treated with vitamin K antagonists (VKAs) have unstable anticoagulation. OBJECTIVE: To assess the stability of VKA therapy in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Camilleri, Eleonora, van Rein, Nienke, van der Meer, Felix J. M., Nierman, Melchior C., Lijfering, Willem M., Cannegieter, Suzanne C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511881/
https://www.ncbi.nlm.nih.gov/pubmed/34667920
http://dx.doi.org/10.1002/rth2.12597

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511881/
https://www.ncbi.nlm.nih.gov/pubmed/34667920
http://dx.doi.org/10.1002/rth2.12597

Ejemplares similares